Stockscreener 앱 받기
14.98
4.04%
-0.63
시장 영업 전:
15.04
0.06
+0.40%
전일 마감가:
$15.61
열려 있는:
$15.66
하루 거래량:
15.60M
Relative Volume:
0.67
시가총액:
$3.28B
수익:
$8.22B
순이익/손실:
$28.95M
주가수익비율:
-249.67
EPS:
-0.06
순현금흐름:
$901.06M
1주 성능:
+8.39%
1개월 성능:
+4.17%
6개월 성능:
+8.87%
1년 성능:
-16.69%
1일 변동 폭
$14.89
$15.68
1주일 범위
$13.01
$16.26
52주 변동 폭
$11.20
$23.79
오스카 헬스 Stock (OSCR) Company Profile
명칭
Oscar Health Inc
전화
(646) 403-3677
주소
75 VARICK STREET, NEW YORK
OSCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSCR
Oscar Health Inc
|
14.98 | 4.04B | 8.22B | 28.95M | 901.06M | -0.06 |
|
UNH
Unitedhealth Group Inc
|
261.57 | 228.94B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.51 | 82.29B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
280.47 | 73.95B | 260.93B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
292.48 | 65.48B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
274.94 | 32.07B | 117.76B | 1.21B | 2.39B | 9.95 |
오스카 헬스 Stock (OSCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-07-15 | 다운그레이드 | UBS | Neutral → Sell |
| 2025-07-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-11 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2025-07-02 | 개시 | Barclays | Underweight |
| 2025-06-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-10 | 개시 | Jefferies | Underperform |
| 2024-11-06 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-10-07 | 개시 | UBS | Neutral |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-05-30 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-22 | 개시 | Raymond James | Outperform |
| 2023-11-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-11-16 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-11-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-06-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-01-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-14 | 개시 | Goldman | Sell |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-03-30 | 개시 | Wells Fargo | Overweight |
| 2021-03-29 | 개시 | BofA Securities | Buy |
| 2021-03-29 | 개시 | Cowen | Market Perform |
| 2021-03-29 | 개시 | Credit Suisse | Outperform |
| 2021-03-29 | 개시 | Goldman | Buy |
| 2021-03-29 | 개시 | Morgan Stanley | Overweight |
모두보기
오스카 헬스 주식(OSCR)의 최신 뉴스
The Top 5 Analyst Questions From Oscar Health’s Q2 Earnings Call - Yahoo Finance
19,524 Shares in Oscar Health, Inc. (NYSE:OSCR) Acquired by WealthPlan Investment Management LLC - MarketBeat
OSCR Q2 Deep Dive: Market Morbidity Pressures Offset by Strategic Cost Actions and Product Expansion - Yahoo Finance
Oscar Health (NYSE:OSCR) Downgraded by Wall Street Zen to Sell - MarketBeat
Oscar Health’s 336th-Ranked $310M Volume Hides 29% Revenue Surge and Widening Losses - AInvest
Oscar Health Second Quarter 2025 Earnings: Revenues Disappoint - Yahoo Finance
Oscar Health, Inc. (NYSE:OSCR) Q2 2025 Earnings Call Transcript - MSN
Oscar Health Reports Q2 2025 Revenue Growth Amid Losses - TipRanks
Oscar Health Inc. stock trendline breakdownSmart Safety Strategy With Real Data Analysis - Newser
Oscar Health, Inc. (NYSE:OSCR) Short Interest Up 118.5% in July - MarketBeat
Will Oscar Health Inc. be affected by tariffsVolatility Breakout Trade Watch - thegnnews.com
XTX Topco Ltd Makes New Investment in Oscar Health, Inc. (NYSE:OSCR) - MarketBeat
Oscar Health Rises Amid Dropped Volume as 392nd in Market Activity Amid Mixed Earnings and 2026 Profit Target - AInvest
Using data filters to optimize entry into Oscar Health Inc.Daily Exit and Entry Price Prediction - Newser
Oscar Health shares decline after missing Q2 forecasts - MSN
Wall Street Got Oscar All Wrong (NYSE:OSCR) - Seeking Alpha
Here's Why I Am Buying More Shares of Oscar Health After Earnings - The Motley Fool
Oscar Health, Inc. (OSCR) Reports Q2 Loss, Misses Revenue Estimates - MSN
Oscar Health’s Earnings Call: Growth Amid Challenges - TipRanks
Oscar Health Surges 5.72% Despite Q2 Net Loss as $380M Volume Ranks 304th in Daily Liquidity - AInvest
BIT Capital GmbH Buys 47,592 Shares of Oscar Health, Inc. (NYSE:OSCR) - MarketBeat
Oscar Health’s ICHRA push continues - Endpoints News
Cautious Outlook: Oscar Health’s Financial Challenges and Sell Recommendation Amid Industry Uncertainties - TipRanks
Oscar Health remains bullish on recovery amid insurance industry turmoil - Crain's New York Business
Oscar Health (OSCR) Reports US$228 Million Q2 Loss After Last Year's Profit - Yahoo Finance
Oscar Health's ICHRA Gambit: Navigating Regulatory Flexibility to Unlock $12 Billion in 2025 Growth - AInvest
JPMorgan Chase & Co. Reduces Stake in Oscar Health Inc. - GuruFocus
Oscar Health outlines $12B–$12.2B 2025 revenue target and new ICHRA strategy amid market reset - MSN
Oscar Health slips after earnings miss - Sherwood News
Oscar Health's Q2 2025: Key Contradictions in Risk Adjustments, Membership Trends, and Market Positioning - AInvest
Oscar Health's 3.76% Surge Defies 289th Trading Rank Amid 29% Revenue Jump and 2026 Profit Push - AInvest
Oscar Health’s Projections and Market Implications - StocksToTrade
Oscar Health Stock Surge: Buying Opportunity? - timothysykes.com
Oscar Health losses, Match Group outlook, Angi stock surges - Yahoo Finance
Oscar Health Well-Positioned To Manage Market Reset, Eyes Profitability In 2026 - Yahoo Finance
Oscar Health (NYSE:OSCR) Misses Q2 Sales Targets - Yahoo Finance
Oscar Health shares rise 2.71% intraday after reporting Q2 earnings and reaffirming FY guidance. - AInvest
Earnings call transcript: Oscar Health Q2 2025 earnings miss forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: Oscar Health Q2 2025 earnings miss forecasts - Investing.com
Oscar Health Swings to Loss as Forecast, Expects Return to Profitability in 2026 - The Wall Street Journal
Oscar Health's Q2 2025 Earnings: A Pivotal Moment for Long-Term Healthcare Tech Growth? - AInvest
Oscar Health reports Q2 EPS (89c), consensus (84c) - TipRanks
Oscar Health Reports Q2 GAAP EPS of -$0.89, Revenue of $2.86B Misses Expectations - AInvest
Oscar Health Announces Financial Results for Second Quarter 2025 - TradingView
Oscar Health earnings missed by $0.05, revenue fell short of estimates - Investing.com Australia
Oscar Health shares fall after missing second quarter expectations By Investing.com - Investing.com Nigeria
Oscar Health shares fall after missing second quarter expectations - Investing.com
Oscar Health misses Q2 revenue estimates, reaffirms FY guidance - MarketScreener
Earnings Flash (OSCR) Oscar Health Posts Q2 Loss $0.89 a Share, vs. FactSet Est of $0.81 Loss - MarketScreener
Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance - Business Wire
Here's Why I Am Buying More Shares of Oscar Health After Earnings - The Globe and Mail
오스카 헬스 (OSCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
자본화:
|
볼륨(24시간):